G40.B09
Juvenile myoclonic epilepsy, not intractable, without status epilepticus
Juvenile Myoclonic Epilepsy (JME), also known as Janz syndrome, is a common form of idiopathic generalized epilepsy (IGE) that typically manifests between the ages of 12 and 18. It is characterized by a triad of seizure types: myoclonic jerks, generalized tonic-clonic seizures (GTCS), and absence seizures. Myoclonic jerks are the hallmark of the disorder, typically occurring shortly after awakening and often described by patients as 'clumsiness' or 'morning jitters'. The classification 'not intractable' indicates that the condition is successfully managed with anti-seizure medications (ASMs) and the patient is not considered drug-resistant. 'Without status epilepticus' confirms the absence of prolonged seizure activity or recurrent seizures without a return to baseline consciousness. While JME is usually a lifelong condition, it is highly responsive to treatment, though it requires strict adherence to lifestyle modifications and medication.
Clinical Symptoms
- Myoclonic jerks (sudden, brief muscle contractions, usually involving arms and shoulders)
- Bilateral, synchronous jerks occurring most frequently within 1-2 hours of waking
- Generalized tonic-clonic seizures (GTCS), often preceded by a cluster of myoclonic jerks
- Absence seizures (brief staring spells with impaired consciousness)
- Morning 'clumsiness' or dropping objects (e.g., 'coffee-spilling' episodes)
- Photosensitivity (seizures triggered by flickering lights)
- Seizures triggered by sleep deprivation
- Seizures triggered by alcohol consumption or withdrawal
- Preserved consciousness during isolated myoclonic jerks
Common Causes
- Polygenic inheritance patterns
- Mutations in the GABRA1 gene (encoding the alpha-1 subunit of the GABA-A receptor)
- Mutations in the EFHC1 gene (Myoclonin-1)
- Genetic variations in CACNB4 and CLCN2 genes
- Strong family history of generalized epilepsy
- Sleep deprivation (major provocative factor)
- Alcohol intake and subsequent withdrawal
- Psychological stress and fatigue
- Excessive cognitive load or mental exertion
Documentation & Coding Tips
Explicitly identify seizure morphology and clinical triggers to distinguish Juvenile Myoclonic Epilepsy from other generalized syndromes.
Example: Patient is a 16-year-old female with Juvenile Myoclonic Epilepsy presenting with frequent morning myoclonic jerks after nights of sleep deprivation. She reports no episodes of status epilepticus. Condition is currently well-managed on Levetiracetam 500mg BID, categorized as not intractable. Recent EEG showed classic 4-6 Hz polyspike-and-wave discharges. Documentation supports G40.B09 as the primary chronic condition for risk adjustment purposes.
Billing Focus: Specificity of epilepsy syndrome (Juvenile Myoclonic) and response to medication (not intractable).
Document the absence of status epilepticus to ensure correct characterization within the fifth and sixth characters of the G40 series.
Example: The patient experienced a single generalized tonic-clonic seizure last month following alcohol consumption; however, there was no prolonged seizure activity or failure to regain consciousness between episodes, confirming without status epilepticus. The patient's JME remains non-refractory. Billing code G40.B09 is applied based on the lack of intractable features and absence of status history.
Billing Focus: Sixth character '9' for without status epilepticus.
Distinguish between intractable and not intractable based on the patient's adherence and clinical response to at least two appropriately chosen anti-seizure medications.
Example: Patient demonstrates excellent control of myoclonic jerks and tonic-clonic events on monotherapy with Valproate. Seizures are infrequent and patient is compliant. Assessment: Juvenile myoclonic epilepsy, not intractable. This documentation validates the choice of G40.B09 over G40.B19.
Billing Focus: Fifth character '0' for not intractable (pharmacosensitive).
Incorporate EEG findings such as polyspike-and-wave patterns or photoparoxysmal responses to support the clinical diagnosis of JME.
Example: Neurological exam reveals no focal deficits. EEG demonstrates generalized 4-6 Hz polyspike-and-wave activity, maximal in the frontal regions, characteristic of Juvenile Myoclonic Epilepsy. The patient's condition is non-intractable and without status epilepticus. Diagnosis updated to G40.B09. This clinical evidence justifies the use of specialized neurology CPT codes for monitoring.
Billing Focus: Clinical evidence supporting the specific JME diagnosis code.
Document all co-occurring seizure types common in JME, such as absence or generalized tonic-clonic seizures, while maintaining JME as the primary syndromic diagnosis.
Example: Patient exhibits the triad of JME: myoclonic jerks upon awakening, childhood-onset absence seizures, and infrequent generalized tonic-clonic seizures. Currently not intractable on Lamotrigine. No history of status epilepticus. Primary ICD-10 code: G40.B09. Documentation of these subtypes illustrates the complete clinical picture for risk-adjusted payment models.
Billing Focus: Capturing the syndromic nature of the epilepsy rather than just a symptom code like R56.9.
Relevant CPT Codes
-
99214 - Office Outpatient Visit Established Moderate MDM
Typically used for JME follow-up involving medication adjustment, lab review (drug levels), and safety counseling.
-
99213 - Office Outpatient Visit Established Low MDM
Used for routine monitoring of well-controlled JME with stable medication levels.
-
95819 - EEG Awake and Asleep
Standard diagnostic tool to capture the characteristic polyspike-and-wave discharges of JME during various sleep stages.
-
95718 - EEG Monitoring 2-12 Hours with Review
Used for more intensive monitoring if seizure types are unclear or if surgery/neuromodulation is considered.
-
95957 - Digital Analysis of EEG
Advanced analysis used to quantify spike burden in patients with JME.
-
80197 - Valproic Acid Assay
Valproate is a first-line treatment for JME; regular monitoring of blood levels is standard practice.
-
80177 - Levetiracetam Assay
Used to monitor adherence and therapeutic efficacy for JME patients on Levetiracetam.
-
99204 - Office Outpatient Visit New Moderate MDM
Used for the initial comprehensive evaluation of a teenager suspected of having JME.
-
95816 - EEG Routine
Standard screening tool for capturing interictal discharges in patients with suspected myoclonic jerks.
-
96132 - Neuropsychological Testing Evaluation Services
Commonly required to assess cognitive impact of epilepsy and medications in school-aged patients.
Related Diagnoses
- G40.B19 - Juvenile myoclonic epilepsy, intractable, without status epilepticus
- G40.B01 - Juvenile myoclonic epilepsy, not intractable, with status epilepticus
- G40.309 - Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
- G40.409 - Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
- G40.A09 - Absence epileptic syndrome, not intractable, without status epilepticus
- R56.9 - Unspecified convulsions
- G40.802 - Other epilepsy, not intractable, without status epilepticus
- F06.8 - Other specified mental disorders due to known physiological condition
- G40.109 - Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus
- Z92.89 - Personal history of other medical treatment
Hierarchy
- G00-G99 - Diseases of the nervous system
- G40-G47 - Episodic and paroxysmal disorders
- G40 - Epilepsy and recurrent seizures
- G40.B - Juvenile myoclonic epilepsy [Janz's syndrome]
- G40.B0 - Juvenile myoclonic epilepsy, not intractable
- G40.B09 - Juvenile myoclonic epilepsy, not intractable, without status epilepticus